Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Webinar

The CCTA + FFRCT Pathway: Informed Patient Selection, Cath Lab Planning and Treatment

Webinar sponsored by HeartFlow

10/16/2023
Access On-Demand Content Here

HeartFlow

 

Join us for an on-demand webinar on how interventional cardiologists are using CCTA & FFRCT to guide revascularization. We will review the latest data supporting CCTA & FFRCT and discuss how these tools can elevate patient care through real-world cases.

 

Presenters

Glen Fandetti, MD, FACC
Sanger Heart and Vascular Institute
Atrium Health
Charlotte, NC

Michael Nanna, MD, MHS, FSCAI
Yale Heart & Vascular

Ziad A Ali, MD, DPhil
St. Francis Hospital & Heart Center


Advertisement

Advertisement

Advertisement

News

Intravascular Lithotripsy
Shockwave Medical Expands U.S. Peripheral IVL Portfolio with Enhanced Catheter
09/16/2024
The Shockwave E8 catheter is designed to optimize the treatment of patients with calcified femoro-popliteal and below-the-knee peripheral artery disease (PAD), including patients with complex chronic limb-threatening ischemia (CLTI).  
The Shockwave E8 catheter is designed to optimize the treatment of patients with calcified femoro-popliteal and below-the-knee peripheral artery disease (PAD), including patients with complex chronic limb-threatening ischemia (CLTI).  
The Shockwave E8 catheter is...
09/16/2024
Cath Lab Digest
Optical Coherence Tomography (OCT)
OCCUPI Trial: OCT Outperforms Conventional Angiography for Stent Guidance in Complex Cases
09/12/2024
“Our results show that the use of OCT guidance improves clinical outcomes and enhances safety and effectiveness of coronary stenting, reducing cardiac death, MI, stent thrombosis, and the need for revascularisation by 38% in a group of very...
“Our results show that the use of OCT guidance improves clinical outcomes and enhances safety and effectiveness of coronary stenting, reducing cardiac death, MI, stent thrombosis, and the need for revascularisation by 38% in a group of very...
“Our results show that the use...
09/12/2024
Cath Lab Digest
Stenting
REC­CAGEFREE I Trial: Stent Implantation Should Remain Preferred Strategy for Previously Untreated Non-Complex CAD
09/12/2024
Strikingly, patients who received the drug-coated balloon were almost 90% more likely to experience a cardiovascular event after 2 years compared to those receiving standard treatment with drug-eluting stents.
Strikingly, patients who received the drug-coated balloon were almost 90% more likely to experience a cardiovascular event after 2 years compared to those receiving standard treatment with drug-eluting stents.
Strikingly, patients who...
09/12/2024
Cath Lab Digest
Laser atherectomy
AngioDynamics Announces CE Mark Approval in Europe for the Auryon System
09/10/2024
The technology underlying the Auryon Atherectomy System has been shown in clinical studies to be effective in treating lesions ranging from soft plaque to severely calcified[1-3].
The technology underlying the Auryon Atherectomy System has been shown in clinical studies to be effective in treating lesions ranging from soft plaque to severely calcified[1-3].
The technology underlying the...
09/10/2024
Cath Lab Digest
Rural CV Health
Innovative Delivery, Access to Care Necessary to Increase Health Equity for Rural Patients with Heart Disease
09/10/2024
“Rurality creates unique challenges in delivering high quality cardiovascular care and eliminating health inequities. The ACC Board of Trustees Health Equity Task Force Action Plan outlines implementation strategies that address these...
“Rurality creates unique challenges in delivering high quality cardiovascular care and eliminating health inequities. The ACC Board of Trustees Health Equity Task Force Action Plan outlines implementation strategies that address these...
“Rurality creates unique...
09/10/2024
Cath Lab Digest
Non-Invasive Imaging
Hackensack Meridian Mountainside Medical Center Chosen as One of Six Global Sites for Innovative MICRO 2.0 Clinical Trial
09/10/2024
"The Genetesis MICRO 2.0 trial offers an exciting opportunity to explore non-invasive diagnostic tools to help diagnose microvascular dysfunction that could transform how we approach cardiac care," said Dr. Ankitkumar Patel.
"The Genetesis MICRO 2.0 trial offers an exciting opportunity to explore non-invasive diagnostic tools to help diagnose microvascular dysfunction that could transform how we approach cardiac care," said Dr. Ankitkumar Patel.
"The Genetesis MICRO 2.0 trial...
09/10/2024
Cath Lab Digest
NPO
SCOFF Trial Confirms Fasting Not Needed Before Cath Lab Procedures
09/09/2024
Complications were not increased if patients ate normally before minimally invasive heart procedures under sedation. 
Complications were not increased if patients ate normally before minimally invasive heart procedures under sedation. 
Complications were not increased...
09/09/2024
Cath Lab Digest
Non-Cardiac Surgery
ASSURE DES Trial: No Difference in Ischemic Events if Aspirin Interrupted or Continued in Patients With Coronary Stents Undergoing Non-Cardiac Surgery
09/09/2024
The ASSURE DES trial showed no difference in ischemic events or major bleeding between aspirin monotherapy and no antiplatelet therapy in patients with drug-eluting stent(s) undergoing non-cardiac surgery, with a modest increase in minor...
The ASSURE DES trial showed no difference in ischemic events or major bleeding between aspirin monotherapy and no antiplatelet therapy in patients with drug-eluting stent(s) undergoing non-cardiac surgery, with a modest increase in minor...
The ASSURE DES trial showed no...
09/09/2024
Cath Lab Digest
TAVI
NOTION-3 Trial Investigates How to Manage CAD in Patients Undergoing Valve Implantation
09/09/2024
In the NOTION-3 trial, performing percutaneous coronary intervention (PCI) in patients undergoing transcatheter aortic valve implantation (TAVI) significantly reduced death, myocardial infarction or urgent revascularisation compared with TAVI...
In the NOTION-3 trial, performing percutaneous coronary intervention (PCI) in patients undergoing transcatheter aortic valve implantation (TAVI) significantly reduced death, myocardial infarction or urgent revascularisation compared with TAVI...
In the NOTION-3 trial,...
09/09/2024
Cath Lab Digest
T-TEER
Tri.fr Trial: New Evidence for Benefits of Transcatheter Edge-to-Edge Repair in Secondary Tricuspid Regurgitation
09/09/2024
In the Tri.fr trial, tricuspid transcatheter edge-to-edge repair (T-TEER) plus optimal medical therapy resulted in a significant improvement of the primary endpoint including death, cardiovascular hospitalisation, functional class and...
In the Tri.fr trial, tricuspid transcatheter edge-to-edge repair (T-TEER) plus optimal medical therapy resulted in a significant improvement of the primary endpoint including death, cardiovascular hospitalisation, functional class and...
In the Tri.fr trial, tricuspid...
09/09/2024
Cath Lab Digest

Advertisement

Advertisement

Intravascular Lithotripsy
Shockwave Medical Expands U.S. Peripheral IVL Portfolio with Enhanced Catheter
09/16/2024
The Shockwave E8 catheter is designed to optimize the treatment of patients with calcified femoro-popliteal and below-the-knee peripheral artery disease (PAD), including patients with complex chronic limb-threatening ischemia (CLTI).  
The Shockwave E8 catheter is designed to optimize the treatment of patients with calcified femoro-popliteal and below-the-knee peripheral artery disease (PAD), including patients with complex chronic limb-threatening ischemia (CLTI).  
The Shockwave E8 catheter is...
09/16/2024
Cath Lab Digest
Optical Coherence Tomography (OCT)
OCCUPI Trial: OCT Outperforms Conventional Angiography for Stent Guidance in Complex Cases
09/12/2024
“Our results show that the use of OCT guidance improves clinical outcomes and enhances safety and effectiveness of coronary stenting, reducing cardiac death, MI, stent thrombosis, and the need for revascularisation by 38% in a group of very...
“Our results show that the use of OCT guidance improves clinical outcomes and enhances safety and effectiveness of coronary stenting, reducing cardiac death, MI, stent thrombosis, and the need for revascularisation by 38% in a group of very...
“Our results show that the use...
09/12/2024
Cath Lab Digest
Stenting
REC­CAGEFREE I Trial: Stent Implantation Should Remain Preferred Strategy for Previously Untreated Non-Complex CAD
09/12/2024
Strikingly, patients who received the drug-coated balloon were almost 90% more likely to experience a cardiovascular event after 2 years compared to those receiving standard treatment with drug-eluting stents.
Strikingly, patients who received the drug-coated balloon were almost 90% more likely to experience a cardiovascular event after 2 years compared to those receiving standard treatment with drug-eluting stents.
Strikingly, patients who...
09/12/2024
Cath Lab Digest
Clinical Images
An Antisepsis Misfortune: Povidone-Iodine-Induced Chemical Burn Near the Pacemaker Implantation Site
09/12/2024
A 76-year-old woman was scheduled for pacemaker implantation due to sick sinus syndrome. The skin was prepared with the usual povidone-iodine solution. During the procedure, she experienced intense burning and discomfort on the left upper...
A 76-year-old woman was scheduled for pacemaker implantation due to sick sinus syndrome. The skin was prepared with the usual povidone-iodine solution. During the procedure, she experienced intense burning and discomfort on the left upper...
A 76-year-old woman was...
09/12/2024
Journal of Invasive Cardiology
Laser atherectomy
AngioDynamics Announces CE Mark Approval in Europe for the Auryon System
09/10/2024
The technology underlying the Auryon Atherectomy System has been shown in clinical studies to be effective in treating lesions ranging from soft plaque to severely calcified[1-3].
The technology underlying the Auryon Atherectomy System has been shown in clinical studies to be effective in treating lesions ranging from soft plaque to severely calcified[1-3].
The technology underlying the...
09/10/2024
Cath Lab Digest
Rural CV Health
Innovative Delivery, Access to Care Necessary to Increase Health Equity for Rural Patients with Heart Disease
09/10/2024
“Rurality creates unique challenges in delivering high quality cardiovascular care and eliminating health inequities. The ACC Board of Trustees Health Equity Task Force Action Plan outlines implementation strategies that address these...
“Rurality creates unique challenges in delivering high quality cardiovascular care and eliminating health inequities. The ACC Board of Trustees Health Equity Task Force Action Plan outlines implementation strategies that address these...
“Rurality creates unique...
09/10/2024
Cath Lab Digest
Non-Invasive Imaging
Hackensack Meridian Mountainside Medical Center Chosen as One of Six Global Sites for Innovative MICRO 2.0 Clinical Trial
09/10/2024
"The Genetesis MICRO 2.0 trial offers an exciting opportunity to explore non-invasive diagnostic tools to help diagnose microvascular dysfunction that could transform how we approach cardiac care," said Dr. Ankitkumar Patel.
"The Genetesis MICRO 2.0 trial offers an exciting opportunity to explore non-invasive diagnostic tools to help diagnose microvascular dysfunction that could transform how we approach cardiac care," said Dr. Ankitkumar Patel.
"The Genetesis MICRO 2.0 trial...
09/10/2024
Cath Lab Digest
NPO
SCOFF Trial Confirms Fasting Not Needed Before Cath Lab Procedures
09/09/2024
Complications were not increased if patients ate normally before minimally invasive heart procedures under sedation. 
Complications were not increased if patients ate normally before minimally invasive heart procedures under sedation. 
Complications were not increased...
09/09/2024
Cath Lab Digest
Non-Cardiac Surgery
ASSURE DES Trial: No Difference in Ischemic Events if Aspirin Interrupted or Continued in Patients With Coronary Stents Undergoing Non-Cardiac Surgery
09/09/2024
The ASSURE DES trial showed no difference in ischemic events or major bleeding between aspirin monotherapy and no antiplatelet therapy in patients with drug-eluting stent(s) undergoing non-cardiac surgery, with a modest increase in minor...
The ASSURE DES trial showed no difference in ischemic events or major bleeding between aspirin monotherapy and no antiplatelet therapy in patients with drug-eluting stent(s) undergoing non-cardiac surgery, with a modest increase in minor...
The ASSURE DES trial showed no...
09/09/2024
Cath Lab Digest
TAVI
NOTION-3 Trial Investigates How to Manage CAD in Patients Undergoing Valve Implantation
09/09/2024
In the NOTION-3 trial, performing percutaneous coronary intervention (PCI) in patients undergoing transcatheter aortic valve implantation (TAVI) significantly reduced death, myocardial infarction or urgent revascularisation compared with TAVI...
In the NOTION-3 trial, performing percutaneous coronary intervention (PCI) in patients undergoing transcatheter aortic valve implantation (TAVI) significantly reduced death, myocardial infarction or urgent revascularisation compared with TAVI...
In the NOTION-3 trial,...
09/09/2024
Cath Lab Digest

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement